The U.S. Food and Drug Administration said on Tuesday it had approved the first gene therapy for a rare and life-threatening ...
Sol-Gel Technologies (SLGL) fell ~10% in the premarket on Wednesday after the dermatological drug developer announced that ...
Hormone-disrupting chemicals found in disposable water bottles and processed foods may cause or aggravate a potentially ...
Zevaskyn, the first gene therapy for recessive dystrophic epidermolysis bullosa, showed significant wound healing in phase 3 ...
We explore the disconnect between mycological cure and cosmetic recovery in Tinea Versicolor, focusing on managing patient ...
You see these folks on the big screen or hear them on the radio, looking flawless, right? But honestly, even global ...
Adult-onset Still's disease (AOSD) is a rare inflammatory disorder. Thanks to a new initiative, AOSD is now considered to be ...
As a kidney transplant recipient, Paris Malachias was accustomed to dealing with skin cancer. But when a biopsy showed that ...
The field of dermatology has witnessed remarkable progress in the prevention and treatment of skin diseases over the past ...
The Sydney girls live with Xeroderman Pigmentosum (XP), an incredibly rare genetic condition that leaves them unable to ...
Dr Su Lwin from King's College London and Guy's and St Thomas' NHS Foundation Trust has been awarded funding from LifeArc and DEBRA UK to lead a ...
Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced the submission of a Biologics License Application (BLA) to ...